Medicare Enrolled
Dr. Imad Alazem, M.D.
Rheumatology · Dearborn, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alazem from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alazem?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alazem
Dr. Imad Alazem is a rheumatology specialist in Dearborn, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Alazem performed 15,071 Medicare services across 2,047 unique beneficiaries.
Between the years covered by Open Payments, Dr. Alazem received a total of $4,802 from 34 pharmaceutical and/or device companies across 269 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alazem is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 17% volume in MI
$4,802 industry payments
Medicare Practice Summary
Medicare Utilization ↗15,071
Medicare services
Top 17% in MI for rheumatology
2,047
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~754 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infliximab-abda biosimilar injection, 10 mg This code represents the administration of a 10 mg dose of infliximab-abda, a biosimilar medication. It covers the injection of this specific pharmaceutical product. |
8,020 | $29 | $150 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
1,732 | $1 | $2 |
| Denosumab injection (Prolia/Xgeva) | 1,500 | $19 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
647 | $88 | $225 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
369 | $65 | $125 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
305 | $6 | $100 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
275 | $10 | $35 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
249 | $49 | $173 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
194 | $22 | $198 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
187 | $102 | $450 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
179 | $50 | $150 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
170 | $1 | $10 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
100 | $122 | $250 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
84 | $51 | $350 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
66 | $32 | $35 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
64 | $7 | $7 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
64 | $31 | $35 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
64 | $128 | $200 |
| Annual depression screening | 63 | $18 | $25 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
62 | $0 | $20 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
49 | $26 | $60 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
47 | $3 | $10 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
47 | $46 | $60 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
43 | $30 | $171 |
| Knee X-ray, 3 views An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures. |
43 | $42 | $89 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
41 | $47 | $113 |
| X-ray of upper spine, 6 or more views An X-ray imaging test of the upper spine using six or more separate views to capture detailed images of the bones and structures in that area. |
32 | $45 | $125 |
| X-ray of lower and sacral spine, minimum of 4 views An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints. |
29 | $40 | $90 |
| Joint fluid aspiration or injection, medium joint Removal of fluid from a medium-sized joint or injection of medication into the joint space. |
27 | $36 | $172 |
| Home health agency supervision, complex multidisciplinary care Supervision by a physician or allowed practitioner for a patient receiving Medicare-covered services from a participating home health agency. This involves complex and multidisciplinary care modalities, with the patient not present during the supervision. |
27 | $84 | $175 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
26 | $31 | $85 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $124 | $250 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
25 | $12 | $40 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
23 | $35 | $125 |
| Wrist X-ray, 2 views An X-ray imaging test of the wrist using two different angles to visualize the bones and joints. |
20 | $46 | $111 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
19 | $20 | $20 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
18 | $43 | $100 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
18 | $0 | $65 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
17 | $41 | $125 |
| New patient office visit, complex (60-74 min) | 17 | $160 | $350 |
| Injection, methylprednisolone acetate, 40 mg | 17 | $6 | $20 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $141 | $300 |
| Hip X-ray, 1 view An X-ray image of the hip joint taken from a single angle to visualize the bones and surrounding structures. |
14 | $25 | $60 |
| Ankle X-ray, minimum 3 views An X-ray imaging test of the ankle that captures at least three different angles to evaluate the bones and joints. |
13 | $32 | $75 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
13 | $137 | $500 |
| Pneumococcal vaccine, 23-valent A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria. |
11 | $131 | $170 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.4% high complexity
84.0% medium
13.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,802
Total received (2018-2024)
Avg $686/year across 7 years
Top 42% in MI for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
269
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,325 (90.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$477 (9.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,535
2023
$932
2022
$523
2021
$240
2020
$417
2019
$521
2018
$635
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$315
Amgen Inc.
$263
Novartis Pharmaceuticals Corporation
$137
UCB, Inc.
$134
Janssen Biotech, Inc.
$127
PFIZER INC.
$109
AstraZeneca Pharmaceuticals LP
$93
GlaxoSmithKline, LLC.
$84
Fresenius Kabi USA, LLC
$49
Organon Llc
$45
Alexion Pharmaceuticals, Inc.
$44
Actelion Pharmaceuticals US, Inc.
$40
E.R. Squibb & Sons, L.L.C.
$39
Kiniksa Pharmaceuticals International, plc
$21
Fidia Pharma USA Inc.
$17
Phathom Pharmaceuticals, Inc.
$17
Top 3 companies account for 46.5% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$755
Amgen Inc.
$642
GlaxoSmithKline, LLC.
$616
Janssen Biotech, Inc.
$512
ABBVIE INC.
$332
E.R. Squibb & Sons, L.L.C.
$282
Novartis Pharmaceuticals Corporation
$232
AstraZeneca Pharmaceuticals LP
$199
UCB, Inc.
$198
Actelion Pharmaceuticals US, Inc.
$134
Organon LLC
$100
AbbVie Inc.
$100
Horizon Therapeutics plc
$83
Alexion Pharmaceuticals, Inc.
$67
Boehringer Ingelheim Pharmaceuticals, Inc.
$56
Harmony Biosciences LLC
$50
Fresenius Kabi USA, LLC
$49
BOSTON SCIENTIFIC CORPORATION
$48
Organon Llc
$45
Genentech USA, Inc.
$35
Merck Sharp & Dohme Corporation
$32
Horizon Pharma plc
$30
Exact Sciences Corporation
$23
Kiniksa Pharmaceuticals International, plc
$21
Neurelis, Inc.
$19
Kiniksa Pharmaceuticals, Ltd.
$19
Fidia Pharma USA Inc.
$17
SK Life Science, Inc.
$17
Phathom Pharmaceuticals, Inc.
$17
Regeneron Healthcare Solutions, Inc.
$16
Cranial Technologies, Inc
$15
EMD Serono, Inc.
$13
Orthogenrx Inc.
$13
AbbVie, Inc.
$12
Top 3 companies account for 41.9% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · ANORO · Actemra · Arcalyst · BENLYSTA · Briviact · COSENTYX · CYLTEZO · Cimzia · Cologuard Collection Kit · Doc Band · EVENITY · Enbrel · FLECTOR PATCH · GenVisc 850 · HADLIMA · HYMOVIS · Humira · IDACIO · ILARIS · INFLECTRA · KESIMPTA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · LYRICA · Mavenclad · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · Prolia · RENFLEXIS · RINVOQ · Rituxan · SAPHNELO · SHINGRIX · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TRELEGY ELLIPTA · TREMFYA · VALTOCO · VOQUEZNA · WAKIX · WATCHMAN · XELJANZ · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
67
Per 100K population
3.8
County median income
$59,521
Nearest hospital
BEAUMONT HOSPITAL - DEARBORN
3.8 mi
3.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alazem is a mixed practice specialist, with above-average Medicare volume (top 17% in MI), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alazem experienced with infliximab-abda biosimilar injection, 10 mg?
Based on Medicare claims data, Dr. Alazem performed 8,020 infliximab-abda biosimilar injection, 10 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alazem receive payments from pharmaceutical companies?
Yes. Dr. Alazem received a total of $4,802 from 34 companies across 269 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alazem's costs compare to other rheumatologists in Dearborn?
Dr. Alazem's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alazem) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Dearborn
Browse rheumatologists in Dearborn ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in MI
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in MI
Which MI rheumatologists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology